INHERIS Trademark

Trademark Overview


On Tuesday, December 18, 2018, a trademark application was filed for INHERIS with the United States Patent and Trademark Office. The USPTO has given the INHERIS trademark a serial number of 88232942. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, May 13, 2020. This trademark is owned by Nektar Therapeutics. The INHERIS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as pain, diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system

Research services, namely, providing research and development services for others in the biotechnical, biomedical and pharmaceutical fields
inheris

General Information


Serial Number88232942
Word MarkINHERIS
Filing DateTuesday, December 18, 2018
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, May 13, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2019

Trademark Statements


Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as pain, diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system
Goods and ServicesResearch services, namely, providing research and development services for others in the biotechnical, biomedical and pharmaceutical fields

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, May 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateWednesday, May 13, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInheris Biopharma, Inc.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCHICAGO, IL 60606

Party NameINHERIS PHARMACEUTICALS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCHICAGO, IL 60606

Party NameNektar Therapeutics
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158

Party NameNektar Therapeutics
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158

Trademark Events


Event DateEvent Description
Wednesday, May 13, 2020ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, May 13, 2020ABANDONMENT - AFTER PUBLICATION
Tuesday, May 12, 2020TEAS EXPRESS ABANDONMENT RECEIVED
Monday, May 11, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 11, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 11, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 8, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2020EXTENSION 1 GRANTED
Friday, December 20, 2019EXTENSION 1 FILED
Monday, January 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 20, 2019TEAS EXTENSION RECEIVED
Wednesday, November 27, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 14, 2019ASSIGNED TO EXAMINER
Wednesday, January 9, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 21, 2018NEW APPLICATION ENTERED IN TRAM